​製薬マネー論文

Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan

No.

Date:

Title:

17

Authors:

Kana Yamamoto, Anju Murayama, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Tetsuya Tanimoto

First Author:

Kana Yamamoto

Journal/Book:

International Urogynecology Journal

URL:

Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan

No.

Date:

Title:

16

Authors:

Anju Murayama, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Yuki Shimada, Kana Yamamoto, Yosuke Suzuki, Tetsuya Tanimoto

First Author:

Anju Murayama

Journal/Book:

PLOS ONE

URL:

Accuracy of post-publication Financial Conflict of Interest corrections in medical research: a secondary analysis of pharmaceutical company payments to the authors of the CREATE-X trial report in the New England Journal of Medicine

No.

Date:

Title:

18

Authors:

Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Yuki Shimada, Tetsuya Tanimoto

First Author:

Akihiko Ozaki

Journal/Book:

Bioethics

URL:

Response to "Strictness and Transparency in Approval Process of Medical Products: Japanese Situation"

No.

Date:

Title:

15

Authors:

Toyoaki Sawano, Akihiko Ozaki, Hiroaki Saito, Yuki Shimada, Tetsuya Tanimoto

First Author:

Toyoaki Sawano

Journal/Book:

Clinical Pharmacology & Therapeutics

URL:

Overview and Transparency of Non-research Payments to Healthcare Organizations and Healthcare Professionals from Pharmaceutical Companies in Japan: Analysis of Payment Data in 2016

No.

Date:

Title:

14

Authors:

Akihiko Ozaki, Hiroaki Saito, Yuki Senoo, Toyoaki Sawano, Yuki Shimada, Yurie Kobashi, Kana Yamamoto, Yosuke Suzuki, Tetsuya Tanimoto

First Author:

Akihiko Ozaki

Journal/Book:

Health Policy

URL:

Pharmaceutical company payments to Japanese government drug regulation committee members

No.

Date:

Title:

13

Authors:

Sawano T, Ozaki A, Saito H, Shimada Y, Tanimoto T

First Author:

Toyoaki Sawano

Journal/Book:

Clinical Pharmacology & Therapeutics

URL:

Pharmaceutical Company Payments to the Professors of Orthopaedic Surgery Departments in Japan

No.

Date:

Title:

12

Authors:

Hiroaki Saito, Akihiko Ozaki, Toyoaki Sawano, Yuki Shimada, Kana Yamamoto, Yosuke Suzuki, Tetsuya Tanimoto

First Author:

Hiroaki Saito

Journal/Book:

Journal of Bone and Joint Surgery

URL:

Japan's drug regulation framework: aiming for better health or bigger profits

No.

Date:

Title:

11

Authors:

Akihiko Ozaki, Yuki Senoo, Hiroaki Saito, Andy Crump, Tetsuya Tanimoto

First Author:

Akihiko Ozaki

Journal/Book:

International Journal of Health Policy and Management

URL:

Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?

No.

Date:

Title:

10

Authors:

Yurie Kobashi, Makoto Watanabe, Hideaki Kimura, Asaka Higuchi, Akihiko Ozaki

First Author:

Yurie Kobashi

Journal/Book:

International Journal of Health Policy and Management

URL:

Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis

No.

Date:

Title:

9

Authors:

Akihiko Ozaki, Hiroaki Saito, Yosuke Onoue, Toyoaki Sawano, Yuki Shimada, Yurie Somekawa, Aritsune Tsuji, Tetsuya Tanimoto

First Author:

Akihiko Ozaki

Journal/Book:

BMJ Open

URL:

Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan

No.

Date:

Title:

8

Authors:

Hiroaki Saito, Yuta Tani, Akihiko Ozaki, Toyoaki Sawano, Yuki Shimada, Kana Yamamoto, Tetsuya Tanimoto

First Author:

Hiroaki Saito

Journal/Book:

Clinical Microbiology and Infection

URL:

Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan

No.

Date:

Title:

7

Authors:

Toyoaki Sawano, Akihiko Ozaki, Hiroaki Saito, Yuki Shimada, Tetsuya Tanimoto

First Author:

Toyoaki Sawano

Journal/Book:

JAMA Network Open

URL:

Transparency of clinical evidence for medical devices in Europe

No.

Date:

Title:

6

Authors:

Tetsuya Tanimoto, Hiroaki Saito, Toyoaki Sawano, Yuki Shimada, Akihiko Ozaki

First Author:

Tetsuya Tanimoto

Journal/Book:

Lancet

URL:

Evaluation of pharmaceutical company payments and conflict of interest disclosures among oncology clinical practice guideline authors in Japan

No.

Date:

Title:

5

Authors:

Hiroaki Saito, Akihiko Ozaki, Toyoaki Sawano, Yuki Shimada, Tetsuya Tanimoto

First Author:

Hiroaki Saito

Journal/Book:

JAMA Network Open

URL:

Pharmaceutical company payments to executive board members of professional medical associations in Japan

No.

Date:

Title:

4

Authors:

Hiroaki Saito, Akihiko Ozaki, Yasuma Kobayashi, Toyoaki Sawano, Tetsuya Tanimoto

First Author:

Hiroaki Saito

Journal/Book:

JAMA Internal Medicine

URL:

Pharmaceutical company payments to the authors of the Japanese dementia clinical practice guidelines in 2016

No.

Date:

Title:

3

Authors:

Yuki Shimada, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Tetsuya Tanimoto

First Author:

Yuki Shimada

Journal/Book:

Alzheimer's & Dementia: Translational Research & Clinical Interventions

URL:

A call for improved transparency in financial aspects of clinical trials: a case study of the CREATE-X trial in the New England Journal of medicine

No.

Date:

Title:

2

Authors:

Akihiko Ozaki, Morihito Takita, Tetsuya Tanimoto

First Author:

Akihiko Ozaki

Journal/Book:

Investigational New Drugs

URL:

Conflict of interest and the CREATE-X trial in the New England Journal of medicine

No.

Date:

Title:

1

Authors:

Akihiko Ozaki

First Author:

Akihiko Ozaki

Journal/Book:

Science and Engineering Ethics

URL: